Thursday, March 8th is International Women’s Day and as described on the United Nations website:
”It is a day when women are recognized for their achievements without regard to divisions, whether national, ethnic, linguistic, cultural, economic or political. International Women's Day first emerged from the activities of labour movements at the turn of the twentieth century in North America and across Europe.”
The day has become a rallying point for programs, events and coming together in celebration of women and their achievements. However, the challenge is ensuring that for the other 364 days in the year there is still the same focus and commitment to continue enabling women to soar. Here is where Women in Pharma® (WIP) must play a key role.
With the unwavering support of the ISPE, Women in Pharma® has begun providing women in the pharmaceutical industry with:
These are opportunities for all women at ISPE and you will see Women in Pharma® booths or hear about what’s in Women in Pharma® at every major ISPE event around the globe. So, what can you do to support and progress our Women in Pharma® efforts? A few things immediately come to mind:
Bottom line is that there are many ways to support Women in Pharma® - and we welcome everyone’s enthusiasm and energy to keep Women in Pharma® active and vital for 365 days a year!
Since starting with ISPE, Edyna Miguez, has had the incredible opportunity to connect with women across the globe working within the pharmaceutical industry, as part of the ISPE Women in Pharma® program. The tenure of these rising female leaders varies, as do their cultural backgrounds. However, one fact remains consistent: they are looking to make the industry a more equitable and...
The ISPE GAMP® 5 Guide (Second Edition) was published on 29 July 2022. It was presented and discussed at the 2023 ISPE Europe Annual Conference, the 2023 ISPE Annual Meeting & Expo, and at several local...
The importance of the 2024 ISPE Europe Annual Conference is evident with the continuous challenges the pharmaceutical industry is facing in terms of drug shortages, regulatory requirements, digitalization, automation, and big data management.